Pfizer Ltd

₹ 4,473 1.65%

18 May - close price

About

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.^[1]
It is the 3rd largest multinational pharmaceutical company in India.^[2]

Key Points

Product Portfolio
Presently, the company sells ~150 different products across 15+ therapeutic areas viz. anti-allergic, anti-diabetic, anti-infectives, cardiovascular, gastrointestinal, neurology, pain, respiratory, vitamin/minerals, antibiotics, etc.^[1]^[2]

Website BSE NSE

Market Cap ₹ 20,463 Cr.
Current Price ₹ 4,473
High / Low ₹ 5,000 / 3,720
Stock P/E 37.5
Book Value ₹ 786
Dividend Yield 0.78 %
ROCE 21.9 %
ROE 16.0 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 28.2%

Cons

The company has delivered a poor sales growth of 1.05% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	535	749	636	676	550	593	637	622	573	531	575	540	547
	409	463	447	481	384	401	406	418	391	421	393	387	357
Operating Profit	126	286	189	195	165	192	232	203	182	111	183	153	189
OPM %	24%	38%	30%	29%	30%	32%	36%	33%	32%	21%	32%	28%	35%
	37	12	15	18	17	-118	213	27	12	33	36	44	75
Interest	4	2	2	2	4	4	3	4	3	3	3	3	7
Depreciation	27	27	27	27	34	27	26	26	26	16	15	18	14
Profit before tax	132	269	175	184	145	43	415	201	165	126	201	176	244
Tax %	24%	26%	18%	22%	13%	25%	25%	25%	21%	26%	26%	26%	27%
	101	200	143	144	126	33	311	151	130	94	149	130	179
EPS in Rs	21.98	43.70	31.25	31.46	27.50	7.12	68.00	32.93	28.34	20.44	32.56	28.41	39.10
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	1,049	1,112	1,853	2,012	1,966	1,969	2,082	2,152	2,239	2,611	2,425	2,193
	865	872	1,438	1,579	1,616	1,468	1,516	1,578	1,526	1,775	1,616	1,558
Operating Profit	184	239	414	433	350	501	566	574	712	836	809	635
OPM %	18%	22%	22%	22%	18%	25%	27%	27%	32%	32%	33%	29%
	519	109	44	97	232	114	167	183	81	63	134	188
Interest	2	1	2	1	2	1	2	11	15	11	13	15
Depreciation	8	8	250	58	63	66	71	103	109	115	106	62
Profit before tax	694	340	207	470	517	548	660	642	669	773	824	746
Tax %	27%	35%	66%	35%	35%	34%	35%	21%	26%	21%	24%	26%
	503	221	70	305	337	360	429	509	498	613	624	551
EPS in Rs	168.62	74.01	15.26	66.67	73.62	78.71	93.79	111.29	108.77	133.90	136.38	120.52
Dividend Payout %	19%	486%	82%	22%	27%	25%	24%	297%	32%	26%	29%	29%

Compounded Sales Growth
10 Years:	7%
5 Years:	1%
3 Years:	-1%
TTM:	-10%

Compounded Profit Growth
10 Years:	10%
5 Years:	5%
3 Years:	3%
TTM:	-9%

Stock Price CAGR
10 Years:	14%
5 Years:	8%
3 Years:	-5%
1 Year:	16%

Return on Equity
10 Years:	16%
5 Years:	18%
3 Years:	19%
Last Year:	16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	30	30	46	46	46	46	46	46	46	46	46	46
Reserves	1,665	629	1,927	2,118	2,373	2,637	2,966	3,350	2,347	2,819	3,162	3,550
	0	0	2	2	2	2	2	2	63	39	41	40
	365	318	638	722	840	1,004	926	1,007	810	997	752	593
Total Liabilities	2,060	977	2,614	2,888	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229
	26	20	944	925	902	950	886	973	894	869	749	713
CWIP	0	3	13	3	15	1	0	1	3	1	8	0
Investments	46	44	43	37	0	0	0	0	0	0	0	0
	1,988	909	1,614	1,923	2,343	2,739	3,054	3,432	2,369	3,030	3,244	3,516
Total Assets	2,060	977	2,614	2,888	3,261	3,690	3,940	4,405	3,266	3,901	4,001	4,229

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-16	132	113	345	329	332	98	323	427	667	356	257
	626	103	68	-701	-250	-238	35	1,530	-469	-575	-36	54
	-43	-1,360	-1	-62	-83	-110	-110	-164	-1,571	-181	-346	-235
Net Cash Flow	567	-1,125	181	-417	-3	-17	23	1,690	-1,613	-88	-26	75

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	49	57	32	26	20	29	30	29	18	20	23	31
Inventory Days	181	148	191	167	148	147	189	198	199	173	175	200
Days Payable	165	156	165	157	178	245	213	197	130	102	91	77
Cash Conversion Cycle	65	49	58	36	-10	-69	6	31	87	91	107	154
Working Capital Days	7	25	7	-9	-46	-57	-15	-7	13	-8	7	36
ROCE %	19%	29%	24%	22%	17%	21%	23%	20%	23%	29%	26%

Shareholding Pattern

Numbers in percentages

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	2.07%	2.07%	2.13%	2.20%	2.55%	2.55%	2.77%	2.80%	2.81%	2.82%	3.03%	3.32%
	15.15%	15.15%	15.03%	15.06%	14.83%	14.88%	14.93%	14.89%	14.89%	15.00%	15.15%	15.32%
	18.86%	18.86%	18.92%	18.82%	18.70%	18.65%	18.39%	18.38%	18.37%	18.24%	17.87%	17.42%
No. of Shareholders	1,21,153	1,21,153	1,26,808	1,25,287	1,23,449	1,22,028	1,17,950	1,17,194	1,15,988	1,16,948	1,12,456	1,09,214

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	2.89%	3.01%	4.20%	3.69%	1.89%	2.20%	2.80%	3.32%
	10.53%	11.91%	11.98%	12.66%	14.63%	15.06%	14.89%	15.32%
	22.66%	21.16%	19.90%	19.73%	19.55%	18.82%	18.38%	17.42%
No. of Shareholders	85,570	72,919	76,717	82,750	1,45,980	1,25,287	1,17,194	1,09,214

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Aug 2020
Transcript
PPT
May 2017
Transcript
PPT
Feb 2017
Transcript
PPT
Nov 2016
Transcript
PPT
Aug 2016
Transcript
PPT
May 2016
Transcript
PPT
Feb 2016
Transcript
PPT